Cargando…

Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma

SIMPLE SUMMARY: Classical Hodgkin lymphoma (cHL) is a highly curable disease, with about 80% of patients cured using standard first-line chemotherapy. However, outcomes for relapsed/refractory patients remain unfavorable and there is a critical lack of predictive biomarkers for early identification...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamaison, Claire, Ferrant, Juliette, Gravelle, Pauline, Traverse-Glehen, Alexandra, Ghesquières, Hervé, Tosolini, Marie, Rossi, Cédric, Ysebaert, Loic, Brousset, Pierre, Laurent, Camille, Syrykh, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563296/
https://www.ncbi.nlm.nih.gov/pubmed/36230815
http://dx.doi.org/10.3390/cancers14194893

Ejemplares similares